Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Board of Directors
Share |

 

Executive Committee

 

  • Caitlin Cameron | Board Chair, Chair & CEO, OtoNexus Medical Technologies
  • Leslie Alexandre, DrPH | Board Secretary, President & CEO, Life Science Washington
  • Margaret McCormick, PhD | Board Treasurer, Chief Administrative Officer, Benaroya Research Institute
  • Jan Beck | Vice President & Site Head, Novo Nordisk Research Center Seattle, Inc.
  • Ralph Derrickson | Senior Vice President, Strategy and Corporate Development, Avizia, Inc.
  • Stephen M. Graham | Partner, Fenwick & West LLP
  • Brad Gray | President & CEO, nanoString Technologies, Inc.
  • Oren Lang-Furr | Partner, EY
  • Gustavo Mahler, PhD | President & CEO, AGC Biologics
  • Ron Myers, M.S, J.D. | CEO, Nexgenia Inc.
  • Erik Nilsson | CEO, Deurion, LLC
  • Jens U. Quistgaard, PhD | Chairman, Mirabilis Medica
  • Francisco R. Velázquez, M.D., S.M.

 

Board of Directors 

 

  • Robin Andrulevich | Senior Vice President, People, Juno Therapeutics
  • Susan Ashe | Executive Director, Health Sciences & Services Authority
  • Charles V. Baltic III | Managing Director, Co-Head of Life Sciences, Needham & Company, LLC
  • Bill Brady | President, Brady & Company
  • Alice Chen, PhD | Vice President, Accelerator Corporation
  • Tom Clement | President & CEO, Aqueduct Critical Care
  • John Cox | Senior Vice President-Seattle, Alexandria Real Estate Equities, Inc.
  • Helga Ding, DDS, MBA, MHA | Managing Director, Kaiser Permanente Washington Health Research Institute
  • Sonya F. Erickson | Partner, Cooley LLP
  • Teresa Foy, PhD | Executive Director, Site Head, Celgene
  • Mike Gallatin | Senior Advisor, Frazier Healthcare Partners
  • James B. Hendricks | PhD, President, Seattle Children’s Research Institute
  • Charlotte Hubbert, PhD | Partner – Gates Foundation Venture Capital, Bill & Melinda Gates Foundation
  • Leen Kawas, PharmD & PhD | President & CEO, M3 Biotechnology
  • Jary J. Krauser | CEO, StratusG Consulting
  • Homer Lane | Executive Director & CFO, Benaroya Research Institute  
  • Tim Martin | Director, United States Government Affairs, Amgen
  • Jennifer Olsen | CEO, Resourceful HR
  • Robert W. Overell, PhD | President & CEO, PhaseRx, Inc.
  • Mitchell Parrish, JD, RAC, CIP | Vice President, Legal & Regulatory Affairs, Kinetiq
  • Rhonda Rhyne | President & CEO, Prevencio, Inc. 
  • Ken Roberts, PhD | Vice Dean of Academic and Community Partnerships, Elson S. Floyd College of Medicine, Washington State University
  • Chad Robins | CEO, Adaptive Biotechnologies
  • Niki Robinson, PhD | Vice President of Business Development & Strategy, Fred Hutch
  • Mike Ruhl | Vice President, Seattle Market Lead, BioMed Realty & Trust
  • Randy Schatzman | CEO, Alder BioPharmaceuticals, Inc.
  • Lee Schindler | Partner, Perkins Coie, LLP
  • Andrew T. Serafini, PhD | Partner, Kilpatrick Townsend & Stockton LLP
  • Gregory Sessler | President & CEO, Olympus Respiratory America
  • Ken Stuart, PhD | President & Professor, Center for Infectious Disease Research
  • Matt Stupfel | Vice President & General Manager, EKOS Corporation
  • John Wecker, PhD | President & CEO, Pacific Northwest Research Institute
  • Nancy Whiting, PharmD, BCOPSenior Vice President, Global Medical Affairs, Seattle Genetics, Inc.

 

 

 

 


Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal